An interval of fewer than 30 days between the last immunotherapy dose and the liver transplant increases the rejection risk ...

Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherapy through ...

Investigators have found that the gene Asah1 plays a crucial protective role in preventing the progression of nonalcoholic ...

Liver cancer in the Philippines holds a staggering mortality rate of 11.6 out of 100,000 individuals, compared to the global death rate of 7.8/100,000. This reflects the significant impact of liver ...

Unlike chemotherapy with its known toxicity towards normal body systems, Namodenoson provides protective effectsRamat Gan, Israel, March 03, ...

Although histotripsy can successfully destroy tumors in the liver, longer-term data are still needed to see recurrence rates ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

PET-CT imaging with [18F]fluorodeoxyglucose (FDG) and [18F]fluorocholine (FCH) altered treatment plans in only a tiny ...

New Zealanders now have funded access to a global standard of care treatment for a form of liver cancer, Hepatocellular Carcinoma (HCC), which, unlike many other cancers has a rapidly increasing rate ...